Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sepsis | 13 | 2024 | 2609 | 1.480 |
Why?
|
Out-of-Hospital Cardiac Arrest | 5 | 2024 | 340 | 1.370 |
Why?
|
Hypothermia, Induced | 5 | 2022 | 756 | 1.330 |
Why?
|
Acute Lung Injury | 11 | 2022 | 378 | 1.220 |
Why?
|
Shock, Septic | 10 | 2022 | 774 | 1.130 |
Why?
|
Respiration, Artificial | 20 | 2022 | 2724 | 1.120 |
Why?
|
Intensive Care Units | 22 | 2024 | 3800 | 1.010 |
Why?
|
Hospital Mortality | 20 | 2021 | 5369 | 0.820 |
Why?
|
Fluid Therapy | 5 | 2023 | 587 | 0.810 |
Why?
|
Resuscitation | 7 | 2024 | 679 | 0.780 |
Why?
|
Respiratory Insufficiency | 5 | 2023 | 1241 | 0.770 |
Why?
|
Calcitonin | 3 | 2023 | 329 | 0.710 |
Why?
|
Emergency Medicine | 2 | 2019 | 1223 | 0.670 |
Why?
|
Positive-Pressure Respiration | 7 | 2022 | 713 | 0.630 |
Why?
|
Respiratory Tract Infections | 4 | 2023 | 1014 | 0.630 |
Why?
|
Emergency Service, Hospital | 14 | 2019 | 7956 | 0.620 |
Why?
|
Theophylline | 1 | 2017 | 133 | 0.550 |
Why?
|
Survivors | 3 | 2022 | 2383 | 0.530 |
Why?
|
Benzamides | 1 | 2022 | 1387 | 0.520 |
Why?
|
Pyrazines | 1 | 2022 | 1206 | 0.520 |
Why?
|
Heart Arrest | 4 | 2024 | 1515 | 0.520 |
Why?
|
Adrenal Cortex Hormones | 5 | 2020 | 1893 | 0.470 |
Why?
|
Thiamine | 3 | 2020 | 160 | 0.460 |
Why?
|
Cardiac Output | 1 | 2016 | 838 | 0.440 |
Why?
|
Bronchodilator Agents | 1 | 2017 | 518 | 0.430 |
Why?
|
Protein Precursors | 1 | 2017 | 1135 | 0.430 |
Why?
|
Developed Countries | 2 | 2021 | 452 | 0.430 |
Why?
|
Acute Kidney Injury | 6 | 2022 | 1936 | 0.430 |
Why?
|
Urinary Catheterization | 1 | 2014 | 195 | 0.420 |
Why?
|
Middle Aged | 73 | 2024 | 223740 | 0.410 |
Why?
|
Aged | 61 | 2024 | 171790 | 0.400 |
Why?
|
Ascorbic Acid | 3 | 2020 | 658 | 0.390 |
Why?
|
Shock | 3 | 2020 | 316 | 0.390 |
Why?
|
Catheter-Related Infections | 2 | 2014 | 275 | 0.370 |
Why?
|
Health Care Reform | 2 | 2019 | 1262 | 0.370 |
Why?
|
Tidal Volume | 4 | 2021 | 518 | 0.350 |
Why?
|
Critical Illness | 7 | 2021 | 2754 | 0.350 |
Why?
|
Male | 81 | 2024 | 365249 | 0.350 |
Why?
|
Patient Admission | 2 | 2017 | 1369 | 0.350 |
Why?
|
Female | 80 | 2024 | 397464 | 0.330 |
Why?
|
Hyperbaric Oxygenation | 1 | 2020 | 166 | 0.320 |
Why?
|
Prospective Studies | 32 | 2023 | 54950 | 0.320 |
Why?
|
Aspirin | 4 | 2021 | 3135 | 0.310 |
Why?
|
Taiwan | 4 | 2018 | 524 | 0.310 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2021 | 2763 | 0.310 |
Why?
|
Atracurium | 2 | 2019 | 51 | 0.300 |
Why?
|
Humans | 107 | 2024 | 768887 | 0.300 |
Why?
|
Vasoconstrictor Agents | 5 | 2023 | 657 | 0.300 |
Why?
|
Developing Countries | 3 | 2021 | 2906 | 0.280 |
Why?
|
Antibodies, Neutralizing | 3 | 2021 | 2009 | 0.280 |
Why?
|
Neuromuscular Blocking Agents | 2 | 2019 | 132 | 0.280 |
Why?
|
Oxygen | 3 | 2023 | 4273 | 0.270 |
Why?
|
Adult | 49 | 2024 | 223818 | 0.270 |
Why?
|
Cross Infection | 3 | 2020 | 1425 | 0.270 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2021 | 135 | 0.270 |
Why?
|
Neuromuscular Blockade | 4 | 2021 | 148 | 0.260 |
Why?
|
Cardiopulmonary Resuscitation | 4 | 2022 | 997 | 0.260 |
Why?
|
Blood Gas Analysis | 2 | 2017 | 384 | 0.250 |
Why?
|
Catheterization, Central Venous | 1 | 2010 | 536 | 0.250 |
Why?
|
Cholecalciferol | 2 | 2021 | 557 | 0.250 |
Why?
|
Anti-Bacterial Agents | 6 | 2023 | 7472 | 0.240 |
Why?
|
Severity of Illness Index | 12 | 2021 | 15955 | 0.240 |
Why?
|
Body Mass Index | 3 | 2021 | 13054 | 0.240 |
Why?
|
Angiotensin II | 2 | 2018 | 844 | 0.240 |
Why?
|
Quality of Health Care | 2 | 2021 | 4338 | 0.230 |
Why?
|
Tracheostomy | 1 | 2018 | 430 | 0.230 |
Why?
|
Aged, 80 and over | 15 | 2021 | 59738 | 0.230 |
Why?
|
Endothelial Cells | 1 | 2017 | 3591 | 0.220 |
Why?
|
Physical Exertion | 2 | 2017 | 668 | 0.220 |
Why?
|
Ticlopidine | 1 | 2018 | 730 | 0.220 |
Why?
|
Clinical Protocols | 3 | 2021 | 1445 | 0.220 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2017 | 3253 | 0.210 |
Why?
|
Double-Blind Method | 9 | 2022 | 12469 | 0.210 |
Why?
|
Adenosine Monophosphate | 2 | 2021 | 232 | 0.210 |
Why?
|
Practice Guidelines as Topic | 5 | 2021 | 7460 | 0.210 |
Why?
|
Multicenter Studies as Topic | 2 | 2019 | 1737 | 0.210 |
Why?
|
Immunocompromised Host | 1 | 2018 | 865 | 0.210 |
Why?
|
Ischemic Attack, Transient | 1 | 2018 | 877 | 0.200 |
Why?
|
Lung Injury | 2 | 2017 | 433 | 0.200 |
Why?
|
Alanine | 2 | 2021 | 614 | 0.200 |
Why?
|
Secondary Prevention | 1 | 2018 | 1476 | 0.190 |
Why?
|
Renin | 1 | 2024 | 648 | 0.190 |
Why?
|
Treatment Outcome | 17 | 2023 | 65485 | 0.190 |
Why?
|
Hospitalization | 11 | 2023 | 10845 | 0.190 |
Why?
|
Microcirculation | 2 | 2018 | 1281 | 0.190 |
Why?
|
Guideline Adherence | 3 | 2023 | 2240 | 0.190 |
Why?
|
Pneumonia | 3 | 2019 | 2163 | 0.190 |
Why?
|
Natural Killer T-Cells | 1 | 2024 | 318 | 0.190 |
Why?
|
Logistic Models | 7 | 2021 | 13317 | 0.190 |
Why?
|
Inflammation | 5 | 2024 | 10869 | 0.190 |
Why?
|
Patient Discharge | 3 | 2023 | 3490 | 0.190 |
Why?
|
Mortality | 2 | 2021 | 2915 | 0.180 |
Why?
|
Vitamin D Deficiency | 2 | 2021 | 1388 | 0.180 |
Why?
|
Risk Factors | 22 | 2022 | 74971 | 0.180 |
Why?
|
Hypotension | 3 | 2023 | 888 | 0.180 |
Why?
|
Amiodarone | 1 | 2012 | 217 | 0.170 |
Why?
|
Propensity Score | 4 | 2018 | 1968 | 0.170 |
Why?
|
Treatment Failure | 6 | 2021 | 2663 | 0.170 |
Why?
|
Health Personnel | 3 | 2024 | 3382 | 0.160 |
Why?
|
Immunocompetence | 1 | 2019 | 138 | 0.160 |
Why?
|
Cohort Studies | 17 | 2023 | 41800 | 0.160 |
Why?
|
Renal Replacement Therapy | 2 | 2018 | 282 | 0.160 |
Why?
|
Antiviral Agents | 2 | 2021 | 3069 | 0.160 |
Why?
|
Retrospective Studies | 18 | 2023 | 81892 | 0.150 |
Why?
|
Indonesia | 1 | 2018 | 131 | 0.150 |
Why?
|
Health Status Indicators | 1 | 2013 | 971 | 0.150 |
Why?
|
Defibrillators | 1 | 2018 | 39 | 0.150 |
Why?
|
Multiple Organ Failure | 1 | 2020 | 387 | 0.150 |
Why?
|
Trauma, Nervous System | 1 | 2017 | 35 | 0.150 |
Why?
|
Heat Stroke | 1 | 2017 | 29 | 0.150 |
Why?
|
Outpatients | 2 | 2022 | 1604 | 0.150 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2012 | 775 | 0.140 |
Why?
|
APACHE | 4 | 2021 | 268 | 0.140 |
Why?
|
Drug Therapy, Combination | 6 | 2021 | 6320 | 0.140 |
Why?
|
Sex Factors | 4 | 2013 | 10641 | 0.140 |
Why?
|
Civil Defense | 1 | 2018 | 115 | 0.140 |
Why?
|
Critical Care | 3 | 2019 | 2715 | 0.140 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.130 |
Why?
|
Glucocorticoids | 3 | 2021 | 2167 | 0.130 |
Why?
|
China | 2 | 2019 | 2395 | 0.130 |
Why?
|
Thrombomodulin | 1 | 2017 | 107 | 0.130 |
Why?
|
Oximetry | 2 | 2017 | 462 | 0.130 |
Why?
|
Pyridones | 1 | 2021 | 819 | 0.130 |
Why?
|
Monitoring, Physiologic | 2 | 2016 | 1796 | 0.130 |
Why?
|
Venous Thrombosis | 2 | 2023 | 1321 | 0.130 |
Why?
|
Angiopoietin-2 | 1 | 2017 | 185 | 0.130 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 212 | 0.120 |
Why?
|
Urine | 1 | 2017 | 362 | 0.120 |
Why?
|
Erythrocyte Indices | 1 | 2016 | 143 | 0.120 |
Why?
|
C-Reactive Protein | 3 | 2022 | 3858 | 0.120 |
Why?
|
Creatinine | 3 | 2022 | 1917 | 0.120 |
Why?
|
Odds Ratio | 4 | 2019 | 9682 | 0.120 |
Why?
|
Delivery of Health Care | 4 | 2023 | 5375 | 0.120 |
Why?
|
Triage | 2 | 2020 | 997 | 0.120 |
Why?
|
Vitamins | 2 | 2021 | 1638 | 0.120 |
Why?
|
Permeability | 1 | 2017 | 726 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.120 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2017 | 328 | 0.120 |
Why?
|
Hydrocortisone | 2 | 2019 | 1842 | 0.120 |
Why?
|
Erythrocyte Transfusion | 2 | 2017 | 575 | 0.120 |
Why?
|
Blood | 1 | 2017 | 597 | 0.110 |
Why?
|
Sputum | 1 | 2017 | 517 | 0.110 |
Why?
|
Hemostasis | 1 | 2017 | 468 | 0.110 |
Why?
|
Lactic Acid | 2 | 2016 | 1140 | 0.110 |
Why?
|
Cerebral Hemorrhage | 2 | 2017 | 2660 | 0.110 |
Why?
|
Fever | 2 | 2018 | 1620 | 0.110 |
Why?
|
Stroke | 2 | 2023 | 9756 | 0.110 |
Why?
|
History, 21st Century | 1 | 2019 | 1575 | 0.110 |
Why?
|
Cytokines | 3 | 2024 | 7453 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2017 | 559 | 0.110 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 419 | 0.110 |
Why?
|
United States | 13 | 2023 | 73180 | 0.110 |
Why?
|
Bacterial Infections | 2 | 2018 | 1397 | 0.110 |
Why?
|
Internationality | 2 | 2019 | 1008 | 0.110 |
Why?
|
Occupational Diseases | 1 | 2021 | 1458 | 0.100 |
Why?
|
Time Factors | 8 | 2023 | 40266 | 0.100 |
Why?
|
von Willebrand Factor | 1 | 2017 | 680 | 0.100 |
Why?
|
Prone Position | 2 | 2021 | 203 | 0.100 |
Why?
|
Waist Circumference | 1 | 2016 | 935 | 0.100 |
Why?
|
Databases, Factual | 1 | 2018 | 8095 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6546 | 0.100 |
Why?
|
Workload | 1 | 2018 | 852 | 0.100 |
Why?
|
Executive Function | 1 | 2021 | 1405 | 0.100 |
Why?
|
Mesenchymal Stem Cells | 1 | 2023 | 1672 | 0.100 |
Why?
|
Virus Diseases | 1 | 2018 | 724 | 0.100 |
Why?
|
Hyperglycemia | 2 | 2020 | 1389 | 0.100 |
Why?
|
Central Nervous System | 1 | 2019 | 1345 | 0.100 |
Why?
|
History, 20th Century | 1 | 2019 | 2771 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1124 | 0.090 |
Why?
|
Life Support Systems | 1 | 2010 | 11 | 0.090 |
Why?
|
Patient Positioning | 2 | 2021 | 332 | 0.090 |
Why?
|
Pyrazoles | 1 | 2021 | 2029 | 0.090 |
Why?
|
Tissue Plasminogen Activator | 1 | 2017 | 1165 | 0.090 |
Why?
|
Young Adult | 10 | 2021 | 60110 | 0.090 |
Why?
|
Length of Stay | 4 | 2021 | 6525 | 0.090 |
Why?
|
Health Care Surveys | 2 | 2018 | 2437 | 0.090 |
Why?
|
Running | 1 | 2015 | 490 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2017 | 2359 | 0.090 |
Why?
|
Leukocytes | 1 | 2018 | 2034 | 0.090 |
Why?
|
Partial Pressure | 2 | 2016 | 248 | 0.090 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 2222 | 0.090 |
Why?
|
Comorbidity | 5 | 2019 | 10591 | 0.090 |
Why?
|
Hypoxia, Brain | 1 | 2010 | 139 | 0.090 |
Why?
|
ROC Curve | 4 | 2020 | 3629 | 0.090 |
Why?
|
Prognosis | 4 | 2024 | 30044 | 0.080 |
Why?
|
Age Factors | 3 | 2016 | 18454 | 0.080 |
Why?
|
Health Services Research | 1 | 2016 | 1818 | 0.080 |
Why?
|
Uric Acid | 1 | 2015 | 806 | 0.080 |
Why?
|
Adolescent | 8 | 2021 | 89247 | 0.080 |
Why?
|
Area Under Curve | 3 | 2020 | 1645 | 0.080 |
Why?
|
Triglycerides | 1 | 2016 | 2464 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10397 | 0.080 |
Why?
|
Income | 1 | 2017 | 1878 | 0.080 |
Why?
|
Early Diagnosis | 3 | 2015 | 1195 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2931 | 0.080 |
Why?
|
Prevalence | 4 | 2020 | 15875 | 0.070 |
Why?
|
Thrombosis | 1 | 2021 | 2956 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 8055 | 0.070 |
Why?
|
Administration, Inhalation | 2 | 2014 | 1169 | 0.070 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 26384 | 0.070 |
Why?
|
Emergency Medical Services | 1 | 2018 | 1947 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2019 | 2517 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2014 | 1407 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3518 | 0.060 |
Why?
|
Family | 1 | 2016 | 3208 | 0.060 |
Why?
|
Blood Glucose | 2 | 2018 | 6434 | 0.060 |
Why?
|
Incidence | 5 | 2019 | 21545 | 0.060 |
Why?
|
Sulfoglycosphingolipids | 1 | 2024 | 31 | 0.060 |
Why?
|
Carbon Dioxide | 1 | 2019 | 1149 | 0.060 |
Why?
|
Acute Disease | 3 | 2019 | 7245 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2021 | 9264 | 0.060 |
Why?
|
Diabetes Mellitus | 2 | 2018 | 5892 | 0.060 |
Why?
|
Glucose | 1 | 2016 | 4352 | 0.060 |
Why?
|
Electrocardiography | 1 | 2017 | 6413 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5455 | 0.060 |
Why?
|
Antigens, CD1d | 1 | 2024 | 225 | 0.060 |
Why?
|
Vaccines, Combined | 1 | 2023 | 70 | 0.050 |
Why?
|
Decision Making | 1 | 2017 | 3952 | 0.050 |
Why?
|
Cognition | 1 | 2021 | 7080 | 0.050 |
Why?
|
Hemorrhage | 2 | 2021 | 3465 | 0.050 |
Why?
|
Pediatrics | 1 | 2018 | 3628 | 0.050 |
Why?
|
Infusions, Intravenous | 2 | 2018 | 2231 | 0.050 |
Why?
|
Mental Recall | 2 | 2021 | 1226 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2023 | 22294 | 0.050 |
Why?
|
Nucleocapsid | 1 | 2022 | 62 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2862 | 0.050 |
Why?
|
Cardiotonic Agents | 2 | 2017 | 544 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
Blood Urea Nitrogen | 1 | 2022 | 189 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3239 | 0.050 |
Why?
|
Stroke Volume | 1 | 2016 | 5621 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2022 | 72 | 0.050 |
Why?
|
Remission Induction | 1 | 2018 | 2411 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2018 | 1320 | 0.050 |
Why?
|
Early Termination of Clinical Trials | 1 | 2021 | 70 | 0.050 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12093 | 0.050 |
Why?
|
Pulse Therapy, Drug | 1 | 2021 | 37 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 6213 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8541 | 0.050 |
Why?
|
Risk | 2 | 2018 | 9621 | 0.050 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8559 | 0.040 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2228 | 0.040 |
Why?
|
Medical Futility | 1 | 2021 | 136 | 0.040 |
Why?
|
Physicians | 1 | 2018 | 4607 | 0.040 |
Why?
|
Hypernatremia | 1 | 2020 | 78 | 0.040 |
Why?
|
Survival Rate | 3 | 2019 | 12873 | 0.040 |
Why?
|
Immunization Schedule | 1 | 2021 | 228 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 417 | 0.040 |
Why?
|
Tidal Waves | 1 | 2019 | 3 | 0.040 |
Why?
|
Ischemia | 1 | 2018 | 1900 | 0.040 |
Why?
|
Lung | 2 | 2023 | 10097 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2021 | 373 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2014 | 621 | 0.040 |
Why?
|
Microscopy, Video | 1 | 2018 | 241 | 0.040 |
Why?
|
Quarantine | 1 | 2020 | 186 | 0.040 |
Why?
|
Respiratory Rate | 1 | 2019 | 180 | 0.040 |
Why?
|
Antigens, Viral | 1 | 2021 | 996 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2021 | 990 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 2019 | 292 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2019 | 5323 | 0.030 |
Why?
|
Aftercare | 1 | 2023 | 921 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2014 | 15471 | 0.030 |
Why?
|
Catecholamines | 1 | 2017 | 390 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2020 | 468 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2020 | 603 | 0.030 |
Why?
|
Cause of Death | 2 | 2017 | 3721 | 0.030 |
Why?
|
Heat Exhaustion | 1 | 2015 | 13 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2017 | 579 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2016 | 20244 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2021 | 3438 | 0.030 |
Why?
|
Brain Ischemia | 1 | 2018 | 3008 | 0.030 |
Why?
|
Conscious Sedation | 1 | 2019 | 534 | 0.030 |
Why?
|
Disease Progression | 2 | 2018 | 13677 | 0.030 |
Why?
|
Job Satisfaction | 1 | 2018 | 548 | 0.030 |
Why?
|
Rhabdomyolysis | 1 | 2015 | 150 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2024 | 1665 | 0.030 |
Why?
|
Hospitals, University | 1 | 2016 | 570 | 0.030 |
Why?
|
Hospitalists | 1 | 2018 | 298 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2211 | 0.030 |
Why?
|
Dehydration | 1 | 2015 | 216 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2018 | 1890 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2022 | 3744 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2088 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2016 | 494 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2871 | 0.030 |
Why?
|
Physical Endurance | 1 | 2015 | 370 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 12563 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 790 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1398 | 0.030 |
Why?
|
Hyperuricemia | 1 | 2015 | 223 | 0.030 |
Why?
|
Water-Electrolyte Balance | 1 | 2013 | 326 | 0.020 |
Why?
|
Muscle Strength | 1 | 2017 | 641 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 12252 | 0.020 |
Why?
|
Body Weight | 1 | 2013 | 4628 | 0.020 |
Why?
|
Respiration | 1 | 2019 | 1668 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6085 | 0.020 |
Why?
|
Pandemics | 2 | 2024 | 8745 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14751 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 941 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2018 | 3102 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2014 | 15889 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2020 | 6242 | 0.020 |
Why?
|
Prediabetic State | 1 | 2016 | 548 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3436 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3441 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2017 | 1741 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2014 | 1376 | 0.020 |
Why?
|
Plasma | 1 | 2013 | 585 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39394 | 0.020 |
Why?
|
Health Status | 1 | 2013 | 4095 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2021 | 1483 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10778 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3903 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 12809 | 0.020 |
Why?
|
Hemodynamics | 1 | 2018 | 4199 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2021 | 7148 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 7860 | 0.020 |
Why?
|
Athletes | 1 | 2015 | 1162 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4850 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2714 | 0.020 |
Why?
|
Child | 3 | 2022 | 80969 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2014 | 1309 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11521 | 0.020 |
Why?
|
Coma | 1 | 2010 | 487 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2680 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6346 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2010 | 500 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22381 | 0.020 |
Why?
|
Kidney | 1 | 2021 | 7057 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3311 | 0.020 |
Why?
|
Algorithms | 1 | 2016 | 14199 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3313 | 0.020 |
Why?
|
Health Care Costs | 1 | 2018 | 3270 | 0.010 |
Why?
|
Interdisciplinary Communication | 1 | 2010 | 937 | 0.010 |
Why?
|
Asthma | 1 | 2014 | 6293 | 0.010 |
Why?
|
Survival Analysis | 1 | 2017 | 10115 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5544 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5890 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3908 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 26394 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9375 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 13020 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9499 | 0.010 |
Why?
|
Rats | 1 | 2018 | 23847 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13510 | 0.010 |
Why?
|
Animals | 2 | 2024 | 169408 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2014 | 3683 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4265 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18366 | 0.010 |
Why?
|
Brain | 1 | 2024 | 27476 | 0.010 |
Why?
|
Mice | 1 | 2024 | 82074 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42684 | 0.010 |
Why?
|
Obesity | 1 | 2013 | 13087 | 0.010 |
Why?
|